Vasomotor menopausal symptoms and cardiovascular disease risk in midlife: A longitudinal study

被引:8
|
作者
Dam, V [1 ,2 ,3 ]
Dobson, A. J. [1 ]
Onland-Moret, N. C. [2 ]
van der Schouw, Y. T. [2 ]
Mishra, G. D. [1 ]
机构
[1] Univ Queensland, Sch Publ Hlth, 266 Herston Rd, Brisbane, Qld 4006, Australia
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[3] Netherlands Heart Inst, Moreelsepk 1, NL-3511 EP Utrecht, Netherlands
基金
澳大利亚国家健康与医学研究理事会;
关键词
Cardiovascular disease; Cerebrovascular disease; Coronary heart disease; Vasomotor menopausal symptoms; HOT FLASHES; HORMONE-THERAPY; MORTALITY; FLUSHES;
D O I
10.1016/j.maturitas.2019.12.011
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To ascertain the association between vasomotor menopausal symptoms (VSM), hot flushes and night sweats, and cardiovascular disease, coronary heart disease and cerebrovascular disease. Study design: The study sample comprised 8881 women (aged 45-50 years) with available hospital separation data from the 1946-51 cohort (1996-2016) of the ongoing Australian Longitudinal Study on Women's Health, a national prospective cohort study. Main outcome measures: First fatal or non-fatal cardiovascular disease, coronary heart disease, and cerebrovascular disease events were obtained through linkage with hospital admission data, the National Death Index, and Medicare Benefits Schedule. Hot flushes and night sweats were assessed via questionnaires at each main survey. Additionally, we calculated the duration of symptoms based on whether or not women reported vasomotor menopausal symptoms in each survey. Results: There were 925 cardiovascular disease, 484 coronary heart disease and 154 cerebrovascular disease events. There was no consistent evidence of any association with vasomotor menopausal symptoms, hot flushes and night sweats. We did find marginally statistically significant associations between presence of night sweats and cardiovascular disease (Hazard Ratio = 1.18, 95 % Confidence Interval: 1.01-1.38), and between the duration of vasomotor menopausal symptoms [years] and coronary heart disease (Hazard Ratio(per year) = 1.03, 95 % Confidence Interval: 1.00-1.05). However, given the number of associations tested, these findings could very well have arisen by chance. Conclusion: In this large longitudinal study with 20 years of follow-up and clinical outcomes we did not find a convincing association between vasomotor menopausal symptoms, hot flushes, night sweats and cardiovascular disease, coronary heart disease and cerebrovascular disease.
引用
收藏
页码:32 / 41
页数:10
相关论文
共 50 条
  • [41] Cardiovascular disease risk factors and menopausal status in midlife women from the former Soviet Union
    Miller, AM
    Wilbur, J
    Chandler, PJ
    Sorokin, O
    WOMEN & HEALTH, 2003, 38 (03) : 19 - 36
  • [42] Are Changes in Cardiovascular Disease Risk Factors in Midlife Women Due to Chronological Aging or to the Menopausal Transition?
    Matthews, Karen A.
    Crawford, Sybil L.
    Chae, Claudia U.
    Everson-Rose, Susan A.
    Sowers, Mary Fran
    Sternfeld, Barbara
    Sutton-Tyrrell, Kim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (25) : 2366 - 2373
  • [43] Vasomotor symptoms, cardiovascular risk factors, and cardiovascular disease risk among Chinese postmenopausal women in Hong Kong
    Chair, Sek Ying
    Lo, Sally Wai Sze
    Cheung, Ho Yu
    Sit, Janet Wing Hung
    Wang, Qun
    Zou, Huijing
    WOMEN & HEALTH, 2022, 62 (07) : 621 - 632
  • [44] Nonhormonal Therapies for Menopausal Vasomotor Symptoms
    Christ, Jacob P.
    Navarro, Victor M.
    Reed, Susan D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (13): : 1278 - 1279
  • [45] Menopausal vasomotor symptoms and insulin resistance
    Emily D. Szmuilowicz
    Nature Reviews Endocrinology, 2012, 8 : 701 - 702
  • [46] Fezolinetant (Veozah) for Menopausal Vasomotor Symptoms
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1679): : 97 - 99
  • [47] Role of gabapantin in menopausal vasomotor symptoms
    Singhal, Savita R.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (12): : 1363 - 1363
  • [48] Phytoestrogens for vasomotor menopausal symptoms - Commentary
    不详
    OBSTETRICS AND GYNECOLOGY, 2008, 111 (03): : 769 - 769
  • [49] Midlife Caregivers: At Risk for Cardiovascular Disease?
    Smith, Jennifer
    Fleming, Carlie
    Anderson, Joel G.
    CIRCULATION, 2022, 146
  • [50] Menopausal symptoms in Bangladeshi women in midlife
    Lumsden, Mary Ann
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (07): : 706 - 707